CD49d and CD49e induce cell adhesion-mediated drug resistance through the nuclear factor-kappaB pathway in Burkitt lymphoma

• Autorzy: Takeda , Tsubaki M. , Genno S. , Matsuda T. , Yamamoto Y. , Ueda E. , Imano M. , Satou T. , Nishida S.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

Burkitt's lymphoma; non-Hodgkin's lymphoma; nuclear factor-kappaB; cell adhesion; drug resistance; bone marrow; tumour cell; chemotherapy; bortezomib; apoptosis; patient

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2020
• Tom: 71
• Numer: 4
• Opis fizyczny: p.467-478,fig.,ref.

Twórcy

autor

Takeda

• Division of Pharmacotherapy, Kindai University School of Pharmacy, Kowakae, Higashi-Osaka, Osaka, Japan

autor

Tsubaki M.

• Division of Pharmacotherapy, Kindai University School of Pharmacy, Kowakae, Higashi-Osaka, Osaka, Japan

autor

Genno S.

• Division of Pharmacotherapy, Kindai University School of Pharmacy, Kowakae, Higashi-Osaka, Osaka, Japan

autor

Matsuda T.

• Division of Pharmacotherapy, Kindai University School of Pharmacy, Kowakae, Higashi-Osaka, Osaka, Japan

autor

Yamamoto Y.

• Division of Pharmacotherapy, Kindai University School of Pharmacy, Kowakae, Higashi-Osaka, Osaka, Japan

autor

Ueda E.

• Division of Pharmacotherapy, Kindai University School of Pharmacy, Kowakae, Higashi-Osaka, Osaka, Japan

autor

Imano M.

• Department of Surgery, Kindai University School of Medicine, Osakasayama, Osaka, Japan

autor

Satou T.

• Department of Pathology, Kindai University School of Medicine, Osakasayama, Osaka, Japan

autor

Nishida S.

• Division of Pharmacotherapy, Kindai University School of Pharmacy, Kowakae, Higashi-Osaka 577-8502, Japan

Identyfikatory

DOI

10.26402/jpp.2020.4.02